Language:
English
In:
Cancers, 2022-03-01, Vol.14 (5), p.1267
Description:
The current risk stratification in prostate cancer (PCa) is frequently insufficient to adequately predict disease development and outcome. One hallmark of cancer is telomere maintenance. For telomere maintenance, PCa cells exclusively employ telomerase, making it essential for this cancer entity. However, TERT, the catalytic protein component of the reverse transcriptase telomerase, itself does not suit as a prognostic marker for prostate cancer as it is rather low expressed. We investigated if, instead of
, transcription factors regulating
may suit as prognostic markers. To identify transcription factors regulating
, we developed and applied a new gene regulatory modeling strategy to a comprehensive transcriptome dataset of 445 primary PCa. Six transcription factors were predicted as
regulators, and most prominently, the developmental morphogenic factor PITX1. PITX1 expression positively correlated with telomere staining intensity in PCa tumor samples. Functional assays and chromatin immune-precipitation showed that PITX1 activates
expression in PCa cells. Clinically, we observed that PITX1 is an excellent prognostic marker, as concluded from an analysis of more than 15,000 PCa samples. PITX1 expression in tumor samples associated with (i) increased Ki67 expression indicating increased tumor growth, (ii) a worse prognosis, and (iii) correlated with telomere length.
Subject(s):
Androgens ; Biomarkers ; Brachytherapy ; Cancer therapies ; Cell division ; Chromatin ; DNA methylation ; Gene expression ; Genomes ; Invasiveness ; Linear programming ; Metastases ; Metastasis ; mixed integer linear programming ; modularity ; Mutation ; Optimization ; PITX1 ; Prostate cancer ; Prostatectomy ; regulatory networks ; RNA-directed DNA polymerase ; Semantics ; Surveillance ; Telomerase ; Telomeres ; Transcription factors ; Transcriptomes ; Tumors
ISSN:
2072-6694
E-ISSN:
2072-6694
DOI:
10.3390/cancers14051267
Source:
Academic Search Ultimate
Source:
PubMed Central
Source:
Alma/SFX Local Collection
Source:
DOAJ Directory of Open Access Journals - Not for CDI Discovery
URL:
https://www.ncbi.nlm.nih.gov/pubmed/35267575$$D View this record in MEDLINE/PubMed
Permalink to record